Trials / Completed
CompletedNCT01423305
Phase I Pharmacokinetic Study (BF-BLOCK)
Effect of Charcoal on Gastrointestinal Absorption of Budesonide and Formoterol
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to assess if charcoal prevents the absorption of budesonide and formoterol via GI track. The assessment will be based on comparing the pharmacokinetic parameter area under the concentration-time curve.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide/formoterol capsule. | Oral administration with concomitant charcoal. |
| DRUG | Budesonide/formoterol capsule for oral adm. | Oral administration without concomitant charcoal. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2011-08-25
- Last updated
- 2011-10-21
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01423305. Inclusion in this directory is not an endorsement.